NCT06444529View on ClinicalTrials.gov

A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness

PHASE3CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

November 14, 2024

Study Completion Date

January 8, 2025

Conditions
Ocular Redness
Interventions
DRUG

Apraclonidine Hydrochloride Ophthalmic Solution

Investigational ophthalmic solution applied topically to the eye with a dropper bottle

DRUG

Vehicle

Vehicle (inactive ingredients) applied topically to the eye with a dropper bottle

Trial Locations (5)

16066

Scott & Christie and Associates, PC, Cranberry Township

22046

Emerson Clinical Research Institute, Inc., Falls Church

24502

Piedmont Eye Center, Lynchburg

27529

Oculus Research, Inc., Garner

91204

Global Research Management, Glendale

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY